The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

Jannik Sinner was riding high to start 2024. He had just been ranked as the No. 1 men's tennis player in the world for the first time in his career. By March, though, a near year-long controversy ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said. The Mumbai-based firm is also strengthening its presence in the central ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...